Similar Articles |
|
Pharmaceutical Executive July 1, 2011 Dickmeyer & Rosenbeck |
From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition? |
Scientific American March 2009 Elaine Schattner |
A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment |
American Family Physician November 1, 2000 Neil Abramson & Becky Melton |
Leukocytosis: Basics of Clinical Assessment Leukocytosis, a common laboratory finding, is most often due to relatively benign conditions (infections or inflammatory processes). Much less common but more serious causes include primary bone marrow disorders... |
Scientific American January 2009 Charles Q. Choi |
Do White Blood Cells Make Cancer Deadly? The ability to spread underlies the killing power of cancer. The process occurs, John Pawelek thinks, when tumor cells fuse with white blood cells -- an idea that, if right, could yield new therapies |
Chemistry World March 28, 2014 Michael Parkin |
Rare-cell analysis platform pursues neurodegeneration answers A technique for spotting the small numbers of immune cells that cross the blood -- brain barrier into the cerebral spinal fluid may offer early clues on neurodegenerative disease progression. |
HHMI Bulletin Aug 2011 Richard Saltus |
T-Cell Booster Kits A bioengineer remodels cell surfaces to prod the immune system. |
Chemistry World February 11, 2013 Helen Potter |
A new system for cancer detection Cancer cells have been found to differ from normal cells in several ways, including the make up of their cell membranes. Cancer-cell membranes have been found to contain more anionic lipids than normal cells, leading to an overall negatively charged cell surface. |
Pharmaceutical Executive October 1, 2012 Ben Comer |
Stem Cells: A Promise Deferred? Ideology, politics, and a stilted political debate may be causing pharma to overlook the potential of emerging stem cell therapies in fostering a new generation of cures. |
Bio-IT World February 18, 2004 |
Pathology Goes Molecular New technologies are enabling clinical diagnostic laboratories to pave the way toward more personalized cancer therapies |
IEEE Spectrum August 2006 Schoenbach et al. |
Zap Extreme voltage could be a surprisingly delicate tool in the fight against cancer. The list of effects that scientists have achieved using nanoseconds-long pulses is growing rapidly, though their actual use as a medical treatment is still years away. |
HHMI Bulletin May 2012 Sarah C. P. Williams |
Stephen Quake: Innovative Thinking on Genetic Tests His ideas have already led to a blood test to tell a pregnant woman whether her fetus has Down syndrome. Now, the HHMI investigator is pushing further, to track the success of heart transplants and diagnose autoimmune diseases and allergies. |
Chemistry World July 22, 2013 Kirsty Muirhead |
Circulating cancer cells spiral towards separation A new biochip developed by researchers in Singapore can isolate tumor cells from blood samples, and may one day be an alternative to more invasive methods for tracking later stage cancers. |
BusinessWeek May 27, 2010 Pettypiece & Gibson |
Training the Immune System to Fight Cancer Bristol-Myers' new melanoma drug may be a "game changer." |
Chemistry World April 21, 2011 David Barden |
RNA analysis raises hopes of early cancer diagnosis An improved method for diagnosing colorectal cancer without using invasive techniques has been developed by scientists in China. |
Wired August 2003 Jennifer Kahn |
The End of Cancer (As we Know it) Diagnosis. Chemotherapy. Radiation. Slow painful death. No more. A new era of cancer treatment is dawning. Meet three scientists who are using the revelations of the Human Genome Project to reshape medicine. |
Managed Care August 2004 Thomas Morrow |
10,000 Cells on a Chip Signal Start of New Era of Diagnosis Diseases will soon be defined by biochemical pathways and genetic interactions. Biochips may identify patients likely to respond to therapeutic agents. All of this is a big deal for health plans. |
HHMI Bulletin Aug 2011 |
Seeing is Believing Today, researchers are finding clever ways to deliver long-lasting, healthy genes without triggering a serious immune response. |
Chemistry World June 4, 2015 Thadchajini Retneswaran |
Microfluidic approach to personalised cancer treatment US scientists have developed an innovative microfluidic assay that can accurately predict how patients with a certain type of blood cancer will respond to an anticancer drug. |
Chemistry World May 5, 2011 Simon Hadlington |
Revolutionary new single-cell labelling method Researchers in the US and Canada have combined mass spectrometry with a technique called flow cytometry to follow dozens of biochemical markers on individual cells simultaneously. |
Chemistry World June 11, 2015 Sarah Houlton |
Companies clamour for CAR-T The biopharmaceutical industry is getting excited about chimeric antigen receptor T-cells, or CAR-T cells, designed to harness the cell-killing power of the immune system. |
Chemistry World February 6, 2008 Simon Hadlington |
Better Detection of DNA Synthesis Researchers in the US have developed a new way to detect DNA synthesis in living cells by using click chemistry -- the concept of reacting together two 'high energy' molecules that 'click' together efficiently under mild conditions. |
HHMI Bulletin May 2010 Sarah C.P. Williams |
Young Again Niche cells can reverse the aging of stem cells. |
AskMen.com Jacob Franek |
New Cancer Therapies As cancer research explodes, the availability of new and innovative interventions is expanding almost daily. |
HHMI Bulletin May 2011 Jim Schnabel |
Oxygen on the Brain An ancient cellular program to protect cells when oxygen is low seems crucial for the production of new brain cells. |
The Motley Fool September 25, 2009 Brian Orelli |
Genzyme's Good News. Finally! It's been awhile, hasn't it? |
Managed Care June 2007 Thomas Morrow |
Dendritic Cell Vaccine Hits FDA Roadblock Questions about study design and analysis prompted the FDA to postpone action on Provenge, a treatment for advanced prostate cancer. |
Chemistry World February 25, 2011 Elinor Richards |
Diagnosing diseases with CDs A digital compact disc integrated with a microfluidic device to analyse cells has been developed by scientists in the US. The disc can be inserted into a standard computer disc drive for analysis and could be used to diagnose diseases. |
BusinessWeek September 5, 2005 Kerry Capell |
Meeting Leukemia's Diagnostic Challenge Tests that distinguish among the disease's many forms either cost too much or don't exist. Dr. Torsten Haferlach And Switzerland's Roche Diagnostics may have a solution. |
Chemistry World September 30, 2014 Andy Extance |
Tiny tips reveal cells' chemical secrets US researchers have broken into individual living cells with inexpensive probes that can suck their contents directly into a mass spectrometer. |
Pharmaceutical Executive December 1, 2010 Walter Armstrong |
The Next Wave: Pharm Exec's 2011 Pipeline Report 42 of the best new drugs in development or parked at the FDA |
American Family Physician February 1, 2004 |
Penile Cancer What is cancer?... How does my doctor check for cancer?... How is penile cancer treated? |
Chemistry World February 9, 2012 Harriet Brewerton |
Pressurizing red blood cells for information Scientists in Canada have developed a method to study the changes in red blood cells caused by the most common malaria parasite Plasmodium falciparum. |
BusinessWeek June 27, 2005 Arlene Weintraub |
Stem Cells To Go ViaCell's goal is to mass-produce stem cells from umbilical cord blood. |
Popular Mechanics January 28, 2010 Cassie Rodenberg |
Next-Gen Transplant Techniques Can Stop Organ Rejection About 77 organ transplants are performed each day in the U.S., and more than 101,000 people are on a wait list for body parts such as hearts, skin and veins, according to the Mayo Clinic. |
HHMI Bulletin May 2010 Sarah C.P. Williams |
Lab-Grown Liver New cell culture system solves problem of growing liver cells. |
Scientific American January 17, 2007 Charles Q. Choi |
A Stroke for Stem Cells The brain becomes a target in stem cell clinical trials. |
Chemistry World January 26, 2011 Anna Watson |
Channelling deeper to target breast cancer US scientists have developed a model of the breast ductal system that could be used to discover abnormal cells or deliver drugs at locations further along the ducts than other techniques. The model fits on a slide, enabling on-chip experiments. |
Pharmaceutical Executive July 30, 2007 |
Tomorrow's Drugs A look at the seven top therapies and technologies vying to deliver the next generation of drugs. |
HHMI Bulletin Spring 2013 Sarah C.P. Williams |
Sounding the Alarm Details on how cells detect and respond to foreign DNA may provide clues to autoimmune diseases. |
Chemistry World July 31, 2012 Fiona McKenzie |
Sorting the good from the bad US scientists have found a way to separate cancerous cells from healthy cells by taking advantage of their adhesion properties. Separating cancer cells for analysis is a critical step for determining the recommended course of treatment for patients. |
BusinessWeek September 23, 2010 Rob Waters |
Stem Cells That Save Big Pharma a Bundle Drugmakers hope to save big by using stem cells to test drugs for dangerous side effects long before costly human trials are needed. |
The Motley Fool November 9, 2004 Charly Travers |
Are Stem Cells a Rule Breaker? Does the science offer real hope or just hype? Biotech investors take on enough risk in the normal course of drug development that they do not need to worry about whether or not the underlying technology even works. |
Chemistry World May 9, 2008 Simon Hadlington |
All-in-one gene detection on a chip Scientists in Singapore have invented a tiny machine that can rapidly prepare, purify and genetically analyse blood or other biological samples in less than 20 minutes. |
BusinessWeek June 13, 2005 Catherine Arnst |
Biotech, Finally The past 30 years of biological discoveries, insights into the human genome, and exotic chemical manipulation have unleashed a wave of biological drugs, many of them reengineered human proteins. |
Chemistry World November 13, 2012 Rachel Cooper |
Detecting cancer cells and parasites Scientists in Denmark have designed a new sensor to detect cells that over-express folate receptors, including cancer cells. The sensor consists of an electrochemical platform composed of graphene and peptide nanotubes with folic acid. |
BusinessWeek December 6, 2004 Catherine Arnst |
Cord Blood To The Rescue A study in the Nov. 25 issue of The New England Journal of Medicine confirms that stem cells in blood extracted from the umbilical cords of newborns can help leukemia patients |
The Motley Fool November 28, 2007 Brian Orelli |
Stem Your Expectations of Stem-Cell Discoveries Making "stem" cells out of skin cells isn't all it's cracked up to be. The recent discovery has a long way to go before it can catch up to the research currently being done with stem cells. |
Chemistry World November 27, 2007 James Mitchell Crow |
A Flare for Gene Silencing US scientists have developed nanoparticle probes coated with DNA that release fluorescent 'flares' when they silence genes inside cells. |
The Motley Fool November 2, 2004 Charly Travers |
Biotech's 5-Baggers: Part 3 Year after year, the hottest biotech companies with investors are those with drugs in development for the treatment of cancer. |
The Motley Fool December 11, 2008 Brian Orelli |
ASH Wrap-Up: Alphabet Soup and Drugs Let's take a look at the data that came out of the American Society of Hematology meeting regarding pharmaceutical companies' medications for blood diseases. |